Dr Alyson Janning, in Cincinnati, OH - Audiologist

Dr Alyson Janning, is a Audiologist based in Cincinnati, Ohio. Dr Alyson Janning is licensed to practice in Ohio (license number A.02192) and her current practice location is 5425 Winton Ridge Ln, Cincinnati, Ohio. She can be reached at her office (for appointments etc.) via phone at (513) 363-5316.

NPI number for Dr Alyson Janning is 1124677448 and her current mailing address is 6606 Fountains Blvd Unit 1, West Chester, Ohio. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1124677448.

Contact Information

	Dr Alyson Janning,
	5425 Winton Ridge Ln, Cincinnati, OH 45232-1140
	(513) 363-5316
	Not Available

Healthcare Provider's Profile

Full Name	Dr Alyson Janning
Gender	Female
Speciality	Audiologist
Location	5425 Winton Ridge Ln, Cincinnati, Ohio
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1124677448
Provider Enumeration Date: 09/09/2019
Last Update Date: 09/09/2019

Medical Identifiers

Medical identifiers for Dr Alyson Janning such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1124677448	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
231H00000X	Audiologist	A.02192 (Ohio)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Alyson Janning is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Alyson Janning, 6606 Fountains Blvd Unit 1, West Chester, OH 45069-6124 Ph: (937) 260-8896	Dr Alyson Janning, 5425 Winton Ridge Ln, Cincinnati, OH 45232-1140 Ph: (513) 363-5316

News Archive

Added benefit of multiple sclerosis drug fingolimod not proven, says IQWiG

Since its approval in 2011, the multiple sclerosis drug fingolimod (Gilenya) has already undergone three early benefit assessments, all of which were mainly based on the approval study TRANSFORMS. After a new modification of the therapeutic indication by the regulatory authorities, the Federal Joint Committee again commissioned the German Institute for Quality and Efficiency in Health Care to examine the added benefit of the drug in accordance with the Act on the Reform of the Market for Medicinal Products.

Three Rivers Pharmaceuticals receives FDA expanded labeling for INFERGEN

Three Rivers Pharmaceuticals, LLC, today received expanded labeling from the U.S. Food and Drug Administration (FDA) to include daily use of INFERGEN (Consensus Interferon) in combination with ribavirin (RBV) for retreatment of chronic hepatitis C patients. The expanded labeling targets hepatitis C patients who need retreatment.

Cempra demonstrates solithromycin's potential against urogenital infections at ECCMID

Cempra, Inc., a clinical-stage pharmaceutical company focused on developing differentiated antibiotics to meet critical medical needs in the treatment of bacterial infections, today announced that it will present data at the European Congress of Clinical Microbiology and Infectious Diseases in Berlin, demonstrating solithromycin's potential to treat urogenital infections and combat challenging pathogens such as enterococci and Legionella pneumophila.

PharmaTrust to launch third generation MedCentre remote dispensing system

PharmaTrust is launching the next generation of the MedCentre remote dispensing system with world-class features that redefine and take remote dispensing services to the next level. The MedCentre is a modular, scalable solution designed to meet both patients' need for convenience and counseling and healthcare professionals' responsibility to deliver the highest level of care.

Study supports the implementation of Beckman Coulter's MDW in emergency labs as initial test to detect sepsis

Beckman Coulter announced the results of a prospective study carried out across two European hospitals, which found that Monocyte Distribution Width, in combination with White Blood Cell Count with Differential, has the diagnostic accuracy to detect the risk of sepsis and severe infection upon patient presentation in A&E, particularly when assessed in patients with a lower likelihood of sepsis.

Audiologist in Cincinnati, OH

Mrs. Catherine Haskamp, Audiologist Medicare: Not Enrolled in Medicare Practice Location: 3333 Burnet Ave, Cincinnati, OH 45229 Phone: 513-636-4236 Fax: 513-636-7316
Kirsten Mosko, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 7502 State Rd Ste 4400, Cincinnati, OH 45255 Phone: 513-624-2450
Connect Hearing, Inc. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 9525 Kenwood Rd, Ste 2, Cincinnati, OH 45242 Phone: 513-791-0728 Fax: 513-791-0673
Dora Murphy, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 2123 Auburn Ave, Cincinnati, OH 45219 Phone: 513-421-5558 Fax: 513-632-5804
Audrey Frederick, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 2825 Burnet Ave Ste 330, Cincinnati, OH 45219 Phone: 513-487-7715 Fax: 513-221-8014
Ms. Teresa C. Stehlin, M.A. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 11135 Montgomery Rd, Cincinnati, OH 45249 Phone: 513-793-9600 Fax: 513-793-4928
Hearing Speech And Deaf Center Of Greater Cincinnati Audiologist Medicare: Medicare Enrolled Practice Location: 2825 Burnet Avenue, Suite 330, Cincinnati, OH 45219 Phone: 513-221-0527 Fax: 513-221-8014

Dr Alyson Janning, - Audiologist in Cincinnati, OH